{
  "trial_id": "NCT00281502",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Subject is 18 to 70 years of age, inclusive.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subject has cirrhosis due to chronic HCV infection as documented by:",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subject has evidence of hepatic encephalopathy as evidenced by: Neuro-psychometric Testing (Number Connection Test, Trails Test, etc.).",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subject is non-azotemic (creatinine <1.5mg/dL) and ambulatory at screening.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subject has cirrhosis due to chronic HCV as documented by: pathologic or clinical and radiographic evidence of cirrhosis with a positive HCV RNA PCR level.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subject successfully participated in and continues to meet all eligibility criteria required in Phase A of the study based on completion of tests, Breath Tests, and Radiological Marker.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subject has a Number Connection Test score >50 sec at time of enrollment.",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Subject has received active interferon therapy within 2 weeks of enrollment.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Subject is pregnant or lactating.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Subject has a life expectancy of less than 100 days.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Subject has a history of alcohol abuse within 6 months of enrollment.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Subject has active gastrointestinal bleeding at time of enrollment.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subject has used an agent that alters intestinal motility, eg, methadone, cholestyramine, tricyclic antidepressants.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Subject is unable to take oral medication.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Subject has used neomycin or other antibiotic within 2 weeks of enrollment or is actively using lactulose at time of enrollment.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has cirrhosis due to chronic HCV infection, evidence of hepatic encephalopathy, and meets other inclusion criteria. However, patient has a history of NSAID gastritis and recent admission for UGIB, which may be exclusionary.",
  "_meta": {
    "topic_id": "7",
    "trial_id": "NCT00281502",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}